Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Chronic Migraine Patients: COMPEL Analysis by Treatment Cycle

被引：0
作者：
Brin, Mitchell F. [1 ,2 ]
Winner, Paul [3 ]
Blumenfeld, Andrew M. [4 ]
Eross, Eric J. [5 ]
Orejudos, Amelia [1 ]
Adams, Aubrey Manack [1 ]
机构：
[1] Allergan Plc, Irvine, CA USA
[2] Univ Calif Irvine, Irvine, CA USA
[3] Premiere Res Inst Palm Beach Neurol, Palm Beach Headache Ctr, W Palm Beach, FL USA
[4] Headache Ctr Southern Calif, Neurol Ctr, Carslbad, CA USA
[5] CORE Inst, Scottsdale, AZ USA
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P4.123
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Tolerability and efficacy of almotriptan in the long-term treatment of migraine
    Pascual, J
    Falk, R
    Docekal, R
    Prusinski, A
    Jelencsik, J
    Cabarrocas, X
    Segarra, X
    Luria, X
    Ferrer, P
    [J]. EUROPEAN NEUROLOGY, 2001, 45 (04) : 206 - 213
  • [32] Effects of OnabotulinumtoxinA Treatment on Disability and Quality of Life in Patients with Chronic Migraine with Baseline Allodynia: A COMPEL Subanalysis
    Young, William B.
    Lopez, J. Ivan
    Rothrock, John F.
    Adams, Aubrey Manack
    Blumenfeld, Andrew M.
    [J]. CEPHALALGIA, 2017, 37 : 100 - 101
  • [33] Effects of OnabotulinumtoxinA Treatment on Disability and Quality of Life in Patients with Chronic Migraine with Baseline Allodynia: A COMPEL Subanalysis
    Young, William B.
    Rothrock, John F.
    Lopez, J. Ivan
    Adams, Aubrey Manack
    Blumenfeld, Andrew M.
    [J]. NEUROLOGY, 2018, 90
  • [34] LONG-TERM EXPERIENCE OF ONABOTULINUMTOXINA IN A LARGE SERIES OF CHRONIC MIGRAINE PATIENTS
    Lambru, G.
    Trimboli, M.
    Andreou, A. P.
    Murphy, M.
    Al-Kaisy, A.
    [J]. CEPHALALGIA, 2016, 36 : 47 - 47
  • [35] OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT
    SK Aurora
    DW Dodick
    RE DeGryse
    CC Turkel
    [J]. The Journal of Headache and Pain, 2013, 14
  • [36] OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT
    Aurora, S. K.
    Dodick, D. W.
    DeGryse, R. E.
    Turkel, C. C.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2013, 14
  • [37] Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: What happens after one year?
    Cernuda-Morollon, Eva
    Ramon, Cesar
    Larrosa, Davinia
    Alvarez, Rocio
    Riesco, Nuria
    Pascual, Julio
    [J]. CEPHALALGIA, 2015, 35 (10) : 864 - 868
  • [38] Long-Term Safety and Tolerability of Rizatriptan for Intermittent Acute Treatment of Migraine in Pediatric Migraineurs
    Hewitt, D. J.
    Pearlman, E.
    Lewis, D.
    Hamalainen, M.
    Connor, K.
    Michelson, D.
    Ceesay, P.
    Bachman, R.
    Mozley, Harper L.
    Dupre, N.
    Strickler, N.
    Mahoney, E.
    Lines, C.
    Ho, T. W.
    [J]. HEADACHE, 2012, 52 (05): : 867 - 867
  • [39] Long-Term Safety and Tolerability of Rizatriptan for Intermittent Acute Treatment of Migraine in Pediatric Migraineurs
    Hewitt, David
    Pearlman, Eric
    Lewis, Donald
    Hamalainen, Mirja
    Connor, Kathryn
    Michelson, David
    Ceesay, Paulette
    Bachman, Robert
    Harper-Mozley, Lyn
    Dupre, Nicole
    Strickler, Nancy
    Mahoney, Erin
    Lines, Christopher
    Ho, Tony
    [J]. NEUROLOGY, 2012, 78
  • [40] Safety of Using OnabotulinumtoxinA for the Treatment of Chronic Migraine in Pregnancy
    Summers, J. E.
    Bedrin, K. O.
    Ailani, J.
    Dougherty, C. O.
    [J]. HEADACHE, 2020, 60 : 24 - 25
12345